100 Clinical Results associated with National Institute for Interdisciplinary Science & Technology
Login to view more data
0 Patents (Medical) associated with National Institute for Interdisciplinary Science & Technology
Login to view more data
2,312
Literatures (Medical) associated with National Institute for Interdisciplinary Science & Technology
01 Jan 2025·Bioresource Technology
Retraction notice to “Recent developments in L-glutaminase production and applications – An overview” [Bioresour. Technol. 245 (2017) 1766–1774]
Article
Author: Beevi, Ummalyma Sabeela ; Sukumaran, Rajeev K. ; Mathew, Anil Kuruvilla ; Binod, Parameswaran ; Pandey, Ashok ; Madhavan, Aravind ; Sindhu, Raveendran ; Singh, Sudhir P ; Singh, Sudhir P. ; Abraham, Amith ; Sukumaran, Rajeev K
01 Jan 2025·Bioresource Technology
Retraction notice to “Molecular improvements in microbial α-amylases for enhanced stability and catalytic efficiency” [Bioresour. Technol. 245 (2017) 1740–1748]
Retraction notice to “Expression system for heterologous protein expression in the filamentous fungus Aspergillus unguis” [Bioresource Technol. 245 (2017) 1334–1342]
Article
Author: Sukumaran, Rajeev K. ; Pandey, Ashok ; Madhavan, Aravind ; Sukumaran, Rajeev K
100 Deals associated with National Institute for Interdisciplinary Science & Technology
Login to view more data
100 Translational Medicine associated with National Institute for Interdisciplinary Science & Technology
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.